Spinal Muscular Atrophy (SMA)

Spinal muscular atrophy is a genetic disease that affects the nerves that control muscle movement.

Illustration of DNA
Blog Post

FDA Approves AveXis’ Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

By Jeanene Swanson | May 24, 2019
Blog Post

Introducing New MDA National Ambassador Tana Zwart, and Checking in With Ambassadors Faith Fortenberry and Justin Moy

By Lindsey Baker | April 17, 2019
Featured Article

What Happened to You

By John Scurto | March 28, 2019
A pyramid of tan building blocks with red medical insignia on it
Featured Article

Prepare Yourself

By Donna Albrecht | March 26, 2019
Blog Post

Buy a Shamrock, Grow Hope

By Lindsey Baker | March 13, 2019
Blog Post

Strengthened by Spinraza, Marley Robinson is Tackling College — and Planning for More

By Chris Anselmo | February 28, 2019
Blog Post

Arkansas to Screen Babies for SMA

By MDA Staff | February 7, 2019
Blog Post

Newborn Screening for DMD and BMD: MDA Needs Your Help

By MDA Staff | January 15, 2019
Blog Post

FDA Grants Orphan Drug Designation to Myonexus Therapeutics’ MYO-102 Gene Therapy Drug for Limb-Girdle Muscular Dystrophy Type 2D

By Jeanene Swanson | January 4, 2019
woman using cpap machine to stop choking and snoring from obstructive sleep apnea
Blog Post

NIV Masks: Finding the One That’s Just Right

By Kathy Wechsler | February 29, 2008